EUVIMEDEUVIMED entdecken
Klinische StudieOpen Access · CC BY-NC-SA 4.0

Pilocarpine 1.25% efficacy for management of uncorrected presbyopia (PILE-UP study)

Rohit Saxena, Vinay Gupta, Thirumurthy Velpandian, Tanya Nidhi, Himani Thakur, Jeewan S Titiyal, Namrata Sharma

Indian Journal of Ophthalmology · 2025

DOI: 10.4103/ijo.ijo_96_25 ↗

Kurz gefasst

Klinische Studie in der Zeitschrift Indian Journal of Ophthalmology, 2025. Verfasst von Rohit Saxena und 6 weiteren Autor:innen. Beteiligte Einrichtung: Dr. R. P. Centre for Ophthalmic Sciences, AIIMS New Delhi, India. Hauptthemen laut MEDLINE: Presbyopia, Pilocarpine, Visual Acuity, Refraction, Ocular. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-SA 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aimed to evaluate the efficacy and safety of pilocarpine 1.25% eye drops for improving near vision acuity in presbyopic individuals.

Design

Prospective interventional single-arm clinical trial.

Methods

This single-arm prospective interventional trial includes 50 presbyopic individuals aged between 40 to 55, administered pilocarpine 1.25% eye drops daily once (9 am, Hour 0) for one month. Visual parameters, including distance corrected near visual acuity (DCNVA), near add power, amplitude of accommodation (AoA), and depth of focus (DoF) along with ocular biometric parameters, were assessed at baseline and after one month at hour 3 (12 noon) and hour 6 (3 pm). Adverse effects were monitored.

Results

After one month of pilocarpine treatment, a significant improvement was observed in DCNVA (0.64 ± 0.2 to 0.26 ± 0.11, P < 0.001) along with a decrease in near add power (1.43 ± 0.43 D to 0.42 ± 0.22 D, P < 0.001). The AoA increased (3.23 ± 0.74 D to 3.92 ± 0.93 D, P: 0.005 ), and DoF widened (0.72 ± 0.18 D to 0.81 ± 0.26 D, P: 0.038 ). No change in ocular biometry parameters was observed. The change in DCNVA showed strong positive correlations with change in near add ( r : 0.84, P:

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PresbyopiaPilocarpineVisual AcuityRefraction, OcularAccommodation, OcularHumansProspective StudiesMaleMiddle AgedFemaleOphthalmic SolutionsAdultFollow-Up StudiesTreatment OutcomeMuscarinic Agonists

Stichwörter der Autor:innen

Near correctionnear vision acuitypilocarpinepilocarpine 1.25%presbyopia

Substanzen

PilocarpineOphthalmic SolutionsMuscarinic Agonists

Autor:innen und Institutionen

  • Dr. R. P. Centre for Ophthalmic Sciences, AIIMS New Delhi, India.

Zitieren

APA

Saxena, R., Gupta, V., Velpandian, T., Nidhi, T., Thakur, H., Titiyal, J. S., & Sharma, N. (2025). Pilocarpine 1.25% efficacy for management of uncorrected presbyopia (PILE-UP study). Indian Journal of Ophthalmology. https://doi.org/10.4103/ijo.ijo_96_25

Vancouver

Saxena R, Gupta V, Velpandian T, Nidhi T, Thakur H, Titiyal JS, et al. Pilocarpine 1.25% efficacy for management of uncorrected presbyopia (PILE-UP study). Indian Journal of Ophthalmology. 2025. doi:10.4103/ijo.ijo_96_25

BibTeX
@article{Saxena2025,
  author = {Saxena, Rohit and Gupta, Vinay and Velpandian, Thirumurthy and Nidhi, Tanya and Thakur, Himani and Titiyal, Jeewan S and Sharma, Namrata},
  title = {Pilocarpine 1.25% efficacy for management of uncorrected presbyopia (PILE-UP study)},
  journal = {Indian Journal of Ophthalmology},
  year = {2025},
  doi = {10.4103/ijo.ijo_96_25}
}
Kostenlos starten →